American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer.

[1]  PasteauO.,et al.  The Radium Treatment of Cancer of the Prostate , 1914 .

[2]  H. Elkins,et al.  Treatment of carcinoma of the prostate by interstitial radiation with radio-active gold (Au 198): a preliminary report. , 1952, The Journal of urology.

[3]  W. Whitmore,et al.  Retropubic implantation to iodine 125 in the treatment of prostatic cancer. , 1972, The Journal of urology.

[4]  L L Anderson,et al.  Spacing nomograph for interstitial implants of 125I seeds. , 1976, Medical physics.

[5]  J. Montie,et al.  Carcinoma of the prostate: treatment with pelvic lymphadenectomy and iodine-125 implants. , 1979, Clinical bulletin.

[6]  W. Whitmore,et al.  Complications of 125iodine implantation and pelvic lymphadenectomy in the treatment of prostatic cancer. , 1979, The Journal of urology.

[7]  K. Charyulu.  Transperineal interstitial implantation of prostate cancer: a new method. , 1980, International journal of radiation oncology, biology, physics.

[8]  T. Stamey,et al.  Complication of 125 iodine implantation and pelvic lymphadenectomy for prostatic cancer with special reference to patients who had failed external beam therapy as their initial mode of therapy. , 1981, The Journal of urology.

[9]  F. Bartone,et al.  Transperineal percutaneous I-125 implant of prostate. , 1981, Urology.

[10]  J. Belis,et al.  Clinical results of early stage prostatic cancer treated by pelvic lymphadenectomy and 125iodine implants. , 1982, The Journal of urology.

[11]  H. Holm,et al.  Transrectal ultrasonic volume determination of the prostate--a preoperative and postoperative study. , 1982, The Journal of urology.

[12]  H. Holm,et al.  Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. , 1983, The Journal of urology.

[13]  S. Nag.  Radioactive iodine‐125 implantation for cancer of the prostate , 1985, The Prostate.

[14]  P. Schellhammer,et al.  125Iodine implantation for carcinoma of the prostate: 5-year survival free of disease and incidence of local failure. , 1985, The Journal of urology.

[15]  P. Schellhammer,et al.  Prostate biopsy after definitive treatment by interstitial 125iodine implant or external beam radiation therapy. , 1987, The Journal of urology.

[16]  T. Stamey,et al.  Morphometric and clinical studies on 68 consecutive radical prostatectomies. , 1988, The Journal of urology.

[17]  J. Oesterling,et al.  Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. , 1988, The Journal of urology.

[18]  T. Stamey,et al.  The role of perineural space invasion in the local spread of prostatic adenocarcinoma. , 1989, The Journal of urology.

[19]  T. Stamey,et al.  Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. , 1989, The Journal of urology.

[20]  T. Stamey,et al.  Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate , 1990, Cancer.

[21]  W. Catalona,et al.  Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. , 1990, The Journal of urology.

[22]  K. Wallner,et al.  125iodine reimplantation for locally progressive prostatic carcinoma. , 1990, The Journal of urology.

[23]  A. Rademaker,et al.  Re: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. , 1990, The Journal of urology.

[24]  T. Stamey,et al.  Positive surgical margins at radical prostatectomy: importance of the apical dissection. , 1990, The Journal of urology.

[25]  J. Oesterling,et al.  Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. , 1990, The Journal of urology.

[26]  R. Williams,et al.  Incidence of surgical margin involvement in various forms of radical prostatectomy. , 1990, Urology.

[27]  M. Mihatsch,et al.  Does microinvasion of the capsule and/or micrometastases in regional lymph nodes influence disease-free survival after radical prostatectomy? , 1990, British journal of urology.

[28]  J. Gottesman,et al.  Failure of open radioactive 125iodine implantation to control localized prostate cancer: a study of 41 patients. , 1991, The Journal of urology.

[29]  J. Roy,et al.  CT-based optimized planning for transperineal prostate implant with customized template. , 1991, International journal of radiation oncology, biology, physics.

[30]  J Roy,et al.  An improved method for computerized tomography-planned transperineal 125iodine prostate implants. , 1991, The Journal of urology.

[31]  S. Brosman,et al.  Transrectal ultrasound-guidedinterstitial radiation therapy for localized prostate cancer , 1991 .

[32]  K. Wallner.  Iodine 125 brachytherapy for early stage prostate cancer: new techniques may achieve better results. , 1991, Oncology.

[33]  J. Blasko,et al.  Transperineal ultrasound-guided implantation of the prostate: morbidity and complications. , 1991, Scandinavian journal of urology and nephrology. Supplementum.

[34]  T. Stamey,et al.  Development of prostatic carcinoma. Morphometric and pathologic features of early stages. , 1991, Acta oncologica.

[35]  R. O’Toole,et al.  DNA ploidy and prostate‐specific antigen as prognostic factors in clinically resectable prostate cancer , 1991, Cancer.

[36]  A. Steinfeld,et al.  Pulmonary embolization of iodine-125 seeds following prostate implantation. , 1991, Urology.

[37]  L. Brady,et al.  External beam irradiation versus 125 iodine implant in the definitive treatment of prostate carcinoma. , 1991, International journal of radiation oncology, biology, physics.

[38]  C B Begg,et al.  The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. , 1991, International journal of radiation oncology, biology, physics.

[39]  C. Ling.  Permanent implants using Au-198, Pd-103 and I-125: radiobiological considerations based on the linear quadratic model. , 1992, International journal of radiation oncology, biology, physics.

[40]  T. Stamey,et al.  Predictive value of contralateral biopsies in unilaterally palpable prostate cancer. , 1992, The Journal of urology.

[41]  R. Nath,et al.  A comparison of radial dose functions for 103Pd, 125I, 145Sm, 241Am, 169Yb, 192Ir, and 137Cs brachytherapy sources. , 1992, International journal of radiation oncology, biology, physics.

[42]  J. McNeal.  Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. , 1992, Human pathology.

[43]  P. Scardino,et al.  Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. , 1992, The Journal of urology.

[44]  R Nath,et al.  Some treatment planning considerations for 103Pd and 125I permanent interstitial implants. , 1992, International journal of radiation oncology, biology, physics.

[45]  D. Beyer,et al.  Guided brachytherapy for treatment of confined prostate cancer. , 1992, Urology.

[46]  D. Kuban,et al.  The significance of post-irradiation prostate biopsy with long-term follow-up. , 1992, International journal of radiation oncology, biology, physics.

[47]  T. Stamey,et al.  Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate , 1992, Cancer.

[48]  Blasko,et al.  Brachytherapy and Organ Preservation in the Management of Carcinoma of the Prostate. , 1993, Seminars in radiation oncology.

[49]  N. Olson,et al.  Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy. , 1993, The Journal of urology.

[50]  C C Ling,et al.  A CT-based evaluation method for permanent implants: application to prostate. , 1993, International journal of radiation oncology, biology, physics.

[51]  Galina Pizov,et al.  Correlation of pathologic findings with progression after radical retropubic prostatectomy , 1993, Cancer.

[52]  J Roy,et al.  Short-term morbidity from CT-planned transperineal I-125 prostate implants. , 1993, International journal of radiation oncology, biology, physics.

[53]  T. Stamey,et al.  Invasion of Denonvilliers' fascia in radical prostatectomy specimens. , 1993, The Journal of urology.

[54]  T. Stamey,et al.  Large, organ confined, impalpable transition zone prostate cancer: association with metastatic levels of prostate specific antigen. , 1993, The Journal of urology.

[55]  M. Roach,et al.  Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. , 1993, The Journal of urology.

[56]  P. Walsh,et al.  Relationship Between Perineural Tumor Invasion on Needle Biopsy and Radical Prostatectomy Capsular Penetration in Clinical Stage B Adenocarcinoma of the Prostate , 1993, The American journal of surgical pathology.

[57]  H M Pollack,et al.  Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. , 1993, The Journal of urology.

[58]  T. Stamey,et al.  Pathologic parameters and flow cytometric ploidy analysis in predicting recurrence in carcinoma of the prostate. , 1993, European urology.

[59]  T. D. de Reijke,et al.  Analysis of biopsy findings and implant quality following ultrasonically-guided 125I implantation for localised prostatic carcinoma. , 1993, British journal of urology.

[60]  D. Chan,et al.  The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. , 1993, The Journal of urology.

[61]  P. Walsh,et al.  Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. , 1993, The Journal of urology.

[62]  J Roy,et al.  Fluoroscopic visualization of the prostatic urethra to guide transperineal prostate implantation. , 1994, International journal of radiation oncology, biology, physics.

[63]  P. Carroll,et al.  Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. , 1994, International journal of radiation oncology, biology, physics.

[64]  J. Roy,et al.  Short-term freedom from disease progression after I-125 prostate implantation. , 1994, International journal of radiation oncology, biology, physics.

[65]  P. Walsh,et al.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.

[66]  A. Zietman,et al.  Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical disease-free outcome. , 1994, Urology.

[67]  Richie Jp,et al.  Management of patients with positive surgical margins following radical prostatectomy. , 1994 .

[68]  J. Roy,et al.  Quantifying the effect of dose inhomogeneity in brachytherapy: application to permanent prostatic implant with 125I seeds. , 1994, International journal of radiation oncology, biology, physics.

[69]  J. Hainsworth,et al.  High‐dose, brief duration, multiagent chemotherapy for metastatic breast cancer , 1994, Cancer.

[70]  S Nag,et al.  Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration. , 1995, Urology.

[71]  J. Blasko,et al.  Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma. , 1995, The Journal of urology.

[72]  R. Badalament,et al.  Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens , 1995, Cancer.

[73]  C C Ling,et al.  The relative biological effectiveness of I-125 and Pd-103. , 1995, International journal of radiation oncology, biology, physics.

[74]  M. Terris,et al.  Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies. , 1995, Urology.

[75]  J. Payne,et al.  Original Articles: Prostate Cancer , 1995 .

[76]  L. Anderson,et al.  Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 , 1995 .

[77]  R. Stock,et al.  Prostate brachytherapy: Improvements in prostate volume measurements and dose distribution using interactive ultrasound guided implantation and three-dimensional dosimetry , 1995 .

[78]  A. D'Amico,et al.  A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. , 1995, The Journal of urology.

[79]  P. Humphrey,et al.  Relationship between serum prostate specific antigen, needle biopsy findings, and histopathologic features of prostatic carcinoma in radical prostatectomy tissues , 1995 .

[80]  J. Blasko,et al.  Brachytherapy for prostate cancer , 1995, CA: a cancer journal for clinicians.

[81]  R. Stock,et al.  A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. , 1995, International journal of radiation oncology, biology, physics.

[82]  F. Critz,et al.  Prostate specific antigen‐monitored combination radiotherapy for patients with prostate cancer. I‐125 implant followed by external‐beam radiation , 1995, Cancer.

[83]  J. Roy,et al.  Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. , 1995, International journal of radiation oncology, biology, physics.

[84]  K. Wallner,et al.  103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma. , 1996, International journal of radiation oncology, biology, physics.

[85]  J. Pow-Sang,et al.  Improvement in dosimetry of ultrasound-guided prostate implants with the use of multiple stabilization needles. , 1996, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[86]  F M Waterman,et al.  Limitations of the minimum peripheral dose as a parameter for dose specification in permanent 125I prostate implants. , 1996, International journal of radiation oncology, biology, physics.

[87]  Low risk of perioperative infection without prophylactic antibiotics for transperineal prostate brachytherapy. , 1996, International journal of radiation oncology, biology, physics.

[88]  P. Unger,et al.  Seminal vesicle biopsy: accuracy and implications for staging of prostate cancer. , 1996, Urology.

[89]  W. Butler,et al.  I‐125 Rapid Strand™ loading technique , 1996 .

[90]  J Roy,et al.  Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[91]  P. Unger,et al.  Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma , 1996, Cancer.

[92]  R. Stock,et al.  Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer. , 1996, International journal of radiation oncology, biology, physics.

[93]  D. Bostwick,et al.  Correlation of pretherapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens. , 1996, International Journal of Radiation Oncology, Biology, Physics.

[94]  J. Blasko,et al.  A method for implementing the American Association of Physicists in Medicine Task Group-43 dosimetry recommendations for 125I transperineal prostate seed implants on commercial treatment planning systems. , 1997, International journal of radiation oncology, biology, physics.

[95]  J. Blasko,et al.  Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer. , 1997, International journal of radiation oncology, biology, physics.

[96]  2103 Rectal and urinary morbidity in patients undergoing prostate I-125 implant , 1997 .

[97]  R Oyen,et al.  Cell kinetic measurements in prostate cancer. , 1997, International journal of radiation oncology, biology, physics.

[98]  P L Roberson,et al.  Impact of differences in ultrasound and computed tomography volumes on treatment planning of permanent prostate implants. , 1997, International journal of radiation oncology, biology, physics.

[99]  S. Stokes,et al.  Transperineal ultrasound-guided radioactive seed implantation for organ-confined carcinoma of the prostate. , 1997, International journal of radiation oncology, biology, physics.

[100]  K. Wallner,et al.  CT-based dosimetry for transperineal I-125 prostate brachytherapy. , 1997, International journal of radiation oncology, biology, physics.

[101]  T. Buchholz,et al.  2097 A dose-volume analysis of permanent transperineal prostate brachytherapy , 1997 .

[102]  J. Blasko,et al.  American brachytherapy society survey of current clinical practice for permanent brachytherapy of prostate cancer , 1997 .

[103]  P L Roberson,et al.  Impact of ultrasound and computed tomography prostate volume registration on evaluation of permanent prostate implants. , 1997, International journal of radiation oncology, biology, physics.

[104]  2210 A comparison of MRI and CT based post implant dosimetric assessment of transperineal interstitial permanent prostate brachytherapy , 1997 .

[105]  B W Corn,et al.  Effect of edema on the post-implant dosimetry of an I-125 prostate implant: a case study. , 1997, International journal of radiation oncology, biology, physics.

[106]  1008 Transperineal ultrasound guided brachytherapy for early stage prostate cancer update on clinical experience at seven years , 1997 .

[107]  J J Prete,et al.  The coupling of anisotropy and radial dose functions for 103Pd and 125I for use with a commercial treatment planning system. , 1997, Medical physics.

[108]  S. Nag.  Principles and practice of brachytherapy , 1997 .

[109]  J J Prete,et al.  Source localization following permanent transperineal prostate interstitial brachytherapy using magnetic resonance imaging. , 1997, International journal of radiation oncology, biology, physics.

[110]  M Dattoli,et al.  A simple method to stabilize the prostate during transperineal prostate brachytherapy. , 1997, International journal of radiation oncology, biology, physics.

[111]  M A Moerland,et al.  Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging. , 1997, International journal of radiation oncology, biology, physics.

[112]  M. Zelefsky,et al.  Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer. , 1997, The Journal of urology.

[113]  S Nag,et al.  Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate. , 1997, International journal of radiation oncology, biology, physics.

[114]  A W Partin,et al.  Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.

[115]  Disease-free survival after external beam irradiation and palladium-103 brachytherapy boost for high-risk prostatic carcinoma , 1997 .

[116]  J J Prete,et al.  Comparison of MRI- and CT-based post-implant dosimetric analysis of transperineal interstitial permanent prostate brachytherapy. , 1998, Radiation oncology investigations.

[117]  J J Prete,et al.  A survey of physics and dosimetry practice of permanent prostate brachytherapy in the United States. , 1998, International journal of radiation oncology, biology, physics.

[118]  B. Prestidge,et al.  Clinical impact of implementing the recommendations of AAPM Task Group 43 on permanent prostate brachytherapy using 125I. American Association of Physicists in Medicine. , 1998, International journal of radiation oncology, biology, physics.

[119]  J J Prete,et al.  Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy. , 1998, International journal of radiation oncology, biology, physics.

[120]  J J Prete,et al.  Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy. , 1998, International journal of radiation oncology, biology, physics.

[121]  P. Grimm,et al.  A survey of current clinical practice of permanent prostate brachytherapy in the United States. , 1998, International journal of radiation oncology, biology, physics.

[122]  J J Prete,et al.  Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. , 1998, Radiology.

[123]  R. Stock,et al.  A dose-response study for I-125 prostate implants. , 1998, International journal of radiation oncology, biology, physics.

[124]  B R Prestidge,et al.  Radioisotopic implantation for carcinoma of the prostate: does it work better than it used to? , 1998, Seminars in radiation oncology.